CANO HEALTH INC (CANO) Fundamental Analysis & Valuation

NYSE:CANO • US13781Y2028

Current stock price

2.3 USD
-0.05 (-2.13%)
At close:
1.17 USD
-1.13 (-49.13%)
Pre-Market:

This CANO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CANO Profitability Analysis

1.1 Basic Checks

  • CANO had negative earnings in the past year.
  • CANO had a negative operating cash flow in the past year.
CANO Yearly Net Income VS EBIT VS OCF VS FCFCANO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M -150M -200M

1.2 Ratios

  • CANO's Return On Assets of -47.69% is on the low side compared to the rest of the industry. CANO is outperformed by 85.22% of its industry peers.
Industry RankSector Rank
ROA -47.69%
ROE N/A
ROIC N/A
ROA(3y)-7.72%
ROA(5y)N/A
ROE(3y)-77.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CANO Yearly ROA, ROE, ROICCANO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100

1.3 Margins

  • CANO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CANO Yearly Profit, Operating, Gross MarginsCANO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 -2 -4 -6 -8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CANO Health Analysis

2.1 Basic Checks

  • CANO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CANO has less shares outstanding than it did 1 year ago.
  • CANO has a worse debt/assets ratio than last year.
CANO Yearly Shares OutstandingCANO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 100M 200M 300M
CANO Yearly Total Debt VS Total AssetsCANO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 0.33, we must say that CANO is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CANO (0.33) is worse than 66.09% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.33
ROIC/WACCN/A
WACC5.13%
CANO Yearly LT Debt VS Equity VS FCFCANO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.40 indicates that CANO may have some problems paying its short term obligations.
  • CANO's Current ratio of 0.40 is on the low side compared to the rest of the industry. CANO is outperformed by 91.30% of its industry peers.
  • CANO has a Quick Ratio of 0.40. This is a bad value and indicates that CANO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CANO has a Quick ratio of 0.40. This is amonst the worse of the industry: CANO underperforms 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
CANO Yearly Current Assets VS Current LiabilitesCANO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CANO Growth Analysis

3.1 Past

  • The earnings per share for CANO have decreased strongly by -343.95% in the last year.
  • Looking at the last year, CANO shows a very strong growth in Revenue. The Revenue has grown by 25.69%.
  • The Revenue has been growing by 96.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-343.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-299.43%
Revenue 1Y (TTM)25.69%
Revenue growth 3Y96.42%
Revenue growth 5YN/A
Sales Q2Q%18.51%

3.2 Future

  • CANO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -50.04% yearly.
  • Based on estimates for the next years, CANO will show a small growth in Revenue. The Revenue will grow by 2.24% on average per year.
EPS Next Y-1383.78%
EPS Next 2Y-122.5%
EPS Next 3Y-50.04%
EPS Next 5YN/A
Revenue Next Year16.84%
Revenue Next 2Y1.95%
Revenue Next 3Y2.61%
Revenue Next 5Y2.24%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CANO Yearly Revenue VS EstimatesCANO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
CANO Yearly EPS VS EstimatesCANO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -50 -100 -150

More info and screens

Find the best growth stocksShow best growing peers

0

4. CANO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CANO. In the last year negative earnings were reported.
  • Also next year CANO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CANO Price Earnings VS Forward Price EarningsCANO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CANO Per share dataCANO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400

4.3 Compensation for Growth

  • A cheap valuation may be justified as CANO's earnings are expected to decrease with -50.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-122.5%
EPS Next 3Y-50.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CANO Dividend Analysis

5.1 Amount

  • CANO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CANO Fundamentals: All Metrics, Ratios and Statistics

CANO HEALTH INC

NYSE:CANO (2/2/2024, 8:04:00 PM)

Premarket: 1.17 -1.13 (-49.13%)

2.3

-0.05 (-2.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-09
Earnings (Next)02-27
Inst Owners9.13%
Inst Owner Change-0.06%
Ins Owners387.39%
Ins Owner Change0%
Market Cap12.44M
Revenue(TTM)3.10B
Net Income(TTM)-577.90M
Analysts48.89
Price Target4.85 (110.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-357.38%
Min EPS beat(2)-389.24%
Max EPS beat(2)-325.53%
EPS beat(4)2
Avg EPS beat(4)-77.16%
Min EPS beat(4)-389.24%
Max EPS beat(4)402.66%
EPS beat(8)5
Avg EPS beat(8)-55.04%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.53%
Min Revenue beat(2)-9.27%
Max Revenue beat(2)0.21%
Revenue beat(4)3
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-9.27%
Max Revenue beat(4)5.3%
Revenue beat(8)4
Avg Revenue beat(8)-4.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)295.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-15217%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.37%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-115.87
EYN/A
EPS(NY)-38.06
Fwd EYN/A
FCF(TTM)-32.43
FCFYN/A
OCF(TTM)-27.14
OCFYN/A
SpS573.4
BVpS-22.57
TBVpS-173.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.69%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.72%
ROA(5y)N/A
ROE(3y)-77.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover2.56
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.58%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 0.33
F-Score2
WACC5.13%
ROIC/WACCN/A
Cap/Depr(3y)63.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-343.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-299.43%
EPS Next Y-1383.78%
EPS Next 2Y-122.5%
EPS Next 3Y-50.04%
EPS Next 5YN/A
Revenue 1Y (TTM)25.69%
Revenue growth 3Y96.42%
Revenue growth 5YN/A
Sales Q2Q%18.51%
Revenue Next Year16.84%
Revenue Next 2Y1.95%
Revenue Next 3Y2.61%
Revenue Next 5Y2.24%
EBIT growth 1Y-134.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-168.37%
EBIT Next 3Y43.75%
EBIT Next 5Y35.27%
FCF growth 1Y-48.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.37%
OCF growth 3YN/A
OCF growth 5YN/A

CANO HEALTH INC / CANO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CANO HEALTH INC?

ChartMill assigns a fundamental rating of 1 / 10 to CANO.


What is the valuation status of CANO HEALTH INC (CANO) stock?

ChartMill assigns a valuation rating of 0 / 10 to CANO HEALTH INC (CANO). This can be considered as Overvalued.


Can you provide the profitability details for CANO HEALTH INC?

CANO HEALTH INC (CANO) has a profitability rating of 0 / 10.


Is the dividend of CANO HEALTH INC sustainable?

The dividend rating of CANO HEALTH INC (CANO) is 0 / 10 and the dividend payout ratio is 0%.